When the Covid 19 pandemic broke out in early 2020, everything had to happen quickly. Protective masks were produced, PCR and rapid tests were developed, and free citizen testing was offered at testing centers. And subsequently, the long-awaited Corona vaccination finally arrived. In the course of this, vaccination centers were opened in addition to the existing test centers, which had to store and manage the data of many patients - including in a large city in central Germany, which has been one of our customers since May 2021.
Test centers were set up and it was quickly clear that the bureaucratic effort could not be managed without digital help. Patient data had to be recorded, test results entered and finally sent to people by e-mail. The customer therefore procured over 100 Samsung tablets, which were used in the centers. Now it turned out that it was difficult to keep track which tablets were in use where and when without an overarching management structure. Data protection concerns also became louder: without additional protective measures, patients' data could be leaked.
Then, when the vaccination centers were set up, additional tablets were purchased. The overarching structure was now provided by our Mobile Device Management (MDM) system - MobiVisor ensured the rapid management of the end devices and thus prevented security risks. With the help of the single app mode, users of the terminal devices could no longer quit or leave the predefined applications, and configurations of the MDM no longer allowed the use of unauthorized Wi-Fi networks, for example. Policies dictated usage patterns, and applications that posed a security risk could be blocked. In the case of the Corona test apps, it was also possible to ensure that the digital test results could not be manipulated.